Atlas Trials

Tipifarnib in Treating Patients With Recurrent Bladder Cancer

Clinical trial NCT00047216 · COMPLETED

Trial details

NCT number
NCT00047216
Sponsor
University Health Network, Toronto
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2002-11-01
Primary completion
2006-03-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.